Editorial: Epidemic-Assistance Investigations by the Centers for Disease Control and Prevention—The First 60 Years

بواسطة O'Brien, Thomas R.
منشور في 2011

What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?

بواسطة O'Brien, Thomas R., Jackson, Sarah S.
الحاوية / القاعدة J Interferon Cytokine Res (2019)

Recent Decline in Hepatocellular Carcinoma Rates in the United States

بواسطة Shiels, Meredith S., O’Brien, Thomas R.
الحاوية / القاعدة Gastroenterology (2020)

IL28B-Genotype Testing Now and in the Era of Direct-Acting Antiviral Agents

بواسطة Morgan, Timothy R., O’Brien, Thomas R.
منشور في 2010

Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C

بواسطة O’Brien, Thomas R., Pfeiffer, Ruth M.
الحاوية / القاعدة Open Forum Infect Dis (2015)

Population Genetics and Comparative Genetics of CLDN1, a Gene Involved in Hepatitis C Virus Entry

بواسطة Bekker, Vincent, O’Brien, Thomas R., Chanock, Stephen
منشور في 2009

The role of genetics in hepatic fibrosis amongst HCV patients

بواسطة Park, Heiyoung, O’Brien, Thomas R., Rehermann, Barbara
الحاوية / القاعدة Hepatology (2018)

Possible Role of Hepatitis D Virus in Severe Hepatitis Related to Hepatitis B Virus Reactivation After Therapy for Chronic Hepatitis C

بواسطة Mahale, Parag, Glenn, Jeffrey S., O’Brien, Thomas R.
الحاوية / القاعدة Ann Intern Med (2017)

Interferon-lambda and therapy for chronic hepatitis C virus infection

بواسطة Donnelly, Raymond P., Dickensheets, Harold, O'Brien, Thomas R.
منشور في 2011

What makes the hepatitis C virus evolve?

بواسطة O'Brien, Thomas R, Hartmann, Rune, Prokunina-Olsson, Ludmila
الحاوية / القاعدة eLife (2019)

IFNL4 Genotype is Associated with Virologic Relapse After 8-Week Treatment with Sofosbuvir, Velpatasvir and Voxilaprevir

بواسطة O’Brien, Thomas R., Kottilil, Shyam, Pfeiffer, Ruth M.
الحاوية / القاعدة Gastroenterology (2017)

IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family

بواسطة O'Brien, Thomas R., Prokunina-Olsson, Ludmila, Donnelly, Raymond P.
منشور في 2014

Beasley’s 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention

بواسطة Koshiol, Jill, Liu, Zhiwei, O’Brien, Thomas R., Hildesheim, Allan
الحاوية / القاعدة Cancer Epidemiol (2018)

Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C

بواسطة O'Brien, Thomas R., Lang Kuhs, Krystle A., Pfeiffer, Ruth M.
الحاوية / القاعدة Open Forum Infect Dis (2014)

Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection: a nested cross-sectional study

بواسطة Zhang, Mingdong, O'Brien, Thomas R, Kopp, William C, Goedert, James J
منشور في 2005

Re: Pearlman and Ehleben - Hepatitis C Genotype 1 Virus with Low Viral Load and Rapid Virologic Response to Peginterferon/Ribavirin Obviates a Protease Inhibitor

بواسطة Wang, Alan S., Pfeiffer, Ruth M., Morgan, Timothy R., O'Brien, Thomas R.
منشور في 2014

No Scientific Basis to Restrict 8 Weeks of Treatment with Ledipasvir/Sofosbuvir to Patients with HCV RNA <6,000,000 IU/ml

بواسطة O’Brien, Thomas R., Feld, Jordan J., Kottilil, Shyam, Pfeiffer, Ruth M.
الحاوية / القاعدة Hepatology (2015)

Shortening the duration of therapy for chronic hepatitis C infection

بواسطة Emmanuel, Benjamin, Wilson, Eleanor M, O’Brien, Thomas R, Kottilil, Shyam, Lau, George
الحاوية / القاعدة Lancet Gastroenterol Hepatol (2017)

Meeting Overview: Interferon Lambda—Disease Impact and Therapeutic Potential

بواسطة O'Brien, Thomas R., Young, Howard A., Donnelly, Raymond P., Prokunina-Olsson, Ludmila
الحاوية / القاعدة J Interferon Cytokine Res (2019)

Race or Genetic Makeup for HCV Treatment Decisions?

بواسطة O’Brien, Thomas R., Kottilil, Shyam, Feld, Jordan J., Morgan, Timothy R., Pfeiffer, Ruth M.
الحاوية / القاعدة Hepatology (2017)